Detalles de la búsqueda
1.
Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10/05 Trial.
Br J Cancer
; 127(4): 695-703, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35610366
2.
Phase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes-a Hellenic Cooperative Oncology Group (HeCOG) Trial.
Br J Cancer
; 123(3): 355-361, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32488135
3.
Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?
Cancer Immunol Immunother
; 69(8): 1549-1564, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32303794
4.
An MRI study of immune checkpoint inhibitor-induced musculoskeletal manifestations myofasciitis is the prominent imaging finding.
Rheumatology (Oxford)
; 59(5): 1041-1050, 2020 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32344435
5.
The combination of bevacizumab/temsirolimus after first-line anti-VEGF therapy in advanced renal-cell carcinoma: a clinical and biomarker study.
Int J Clin Oncol
; 24(4): 411-419, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30374686
6.
Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe.
Int J Cancer
; 142(1): 66-80, 2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28857155
7.
Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group.
J Transl Med
; 15(1): 30, 2017 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-28193231
8.
Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes.
Breast Cancer Res Treat
; 158(2): 307-21, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27369359
9.
MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer.
J Transl Med
; 14(1): 136, 2016 05 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-27184134
10.
Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.
J Transl Med
; 13: 171, 2015 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26021752
11.
Comparison of filgrastim and pegfilgrastim to prevent neutropenia and maintain dose intensity of adjuvant chemotherapy in patients with breast cancer.
Support Care Cancer
; 23(7): 2045-51, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25524005
12.
Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial.
BMC Cancer
; 14: 515, 2014 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25026897
13.
ß-Blocker Use and Risk of Recurrence in Patients with Early Breast Cancer.
Chemotherapy
; 60(5-6): 288-9, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25998892
14.
alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies.
BMC Clin Pathol
; 14: 28, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24987308
15.
Current Status and Future Perspectives of Antibody-Drug Conjugates in Hormone Receptor-Positive Breast Cancer.
Cancers (Basel)
; 16(10)2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38791880
16.
Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytes.
Breast
; 73: 103668, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38176305
17.
Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials.
BMC Cancer
; 13: 163, 2013 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-23537287
18.
The combination of antitumor drugs, exemestane and erlotinib, induced resistance mechanism in H358 and A549 non-small cell lung cancer (NSCLC) cell lines.
Pharm Biol
; 2013 Nov 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24192333
19.
Health-related quality of life in patients with solid tumors receiving implantable venous access ports for chemotherapy: A prospective randomized controlled trial.
Eur J Oncol Nurs
; 67: 102445, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37871414
20.
Small Extracellular Vesicles (sEVs) Biogenesis Molecular Players Are Associated with Clinical Outcome of Colorectal Cancer Patients.
Cancers (Basel)
; 15(6)2023 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36980570